Skip to main content

Table 4 Number of adverse events (AE) in relation to dose administered (n = 155)

From: Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

Dose (mg)

200

400

700

1200

2000a

2000b

2000c

Clinical AE (n)

2

0

6

3

16

7

1

Laboratory AE (n)

16

16

16

20

14

12

25

  1. a n = 3 before DLT; b n = 3 after DLT; c n = 3 for 9 weeks